Bruce S Chertow, MD | |
1600 Medical Center Dr, Suite G500, Huntington, WV 25701-3656 | |
(304) 691-1000 | |
(304) 691-1693 |
Full Name | Bruce S Chertow |
---|---|
Gender | Male |
Speciality | Nuclear Medicine |
Location | 1600 Medical Center Dr, Huntington, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043275662 | NPI | - | NPPES |
64693815 | Medicaid | KY | |
0414028 | Medicaid | OH | |
0082914000 | Medicaid | WV |
Mailing Address | Practice Location Address |
---|---|
Bruce S Chertow, MD 1600 Medical Center Dr, Suite G500, Huntington, WV 25701-3656 Ph: (304) 691-1000 | Bruce S Chertow, MD 1600 Medical Center Dr, Suite G500, Huntington, WV 25701-3656 Ph: (304) 691-1000 |
News Archive
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has renewed the contract to continue studying asthma in children living in lower-income, inner-city environments.
Singing mice (Scotinomys teguina) are not your average lab rats. Their fur is tawny brown instead of the common white albino strain; they hail from the tropical cloud forests in the mountains of Costa Rica; and, as their name hints, they use song to communicate.
Chemists at the University of Waterloo, SCIEX and Pfizer have discovered a new way to help the pharmaceutical industry identify and test new drugs, which could revolutionize drug development, and substantially reduce the cost and time drugs need to reach their market.
While determining the risk of severe COVID-19, age, and gender are usually the only considerations. A recent preprint paper published in medRxiv, discusses how researchers from Genetic Technologies Limited, Australia, used the UK Biobank data to develop a comprehensive model that can predict severe COVID-19 risk by incorporating comorbidity risk factors, demographic information, and a set of genetic markers.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the launch of piperacillin and tazobactam for injection in the United States. The medication is a generic version of Zosyn, the world's leading injectable antibiotic, from Pfizer. Piperacillin and tazobactam injection posted 2009 U.S. sales of more than $855 million.
› Verified 6 days ago